Publication
Number of items: 16.
23 December 2024
  • Animal Models of Human Disease 2.0. (2024) Sigrun Lange and Jameel M. Inal
    • 31 October 2023
  • Animal Models of Human Disease. (2023) Sigrun Lange and Jameel Inal
    • 3 March 2023
  • The Impact of Semicarbazide Sensitive Amine Oxidase Activity on Rat Aortic Vascular Smooth Muscle Cells. (2023) Vesna Manasieva, Shori Thakur, Lisa A. Lione, Anwar R. Baydoun and John Skamarauskas
    • 4 August 2022
  • A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species. (2022) Jameel M. Inal, Mariya Hristova and Sigrun Lange
    • 16 August 2021
  • Worsening of the Toxic Effects of (±) Cis -4,4′-DMAR Following Its Co-Administration with (±) Trans -4,4′-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice. (2021) Micaela Tirri, Paolo Frisoni, Sabrine Bilel, Raffaella Arfè, Claudio Trapella, Anna Fantinati, Giorgia Corli, Beatrice Marchetti, Fabio De-Giorgio, Cristian Camuto, Monica Mazzarino, Rosa Maria Gaudio, Giovanni Serpelloni, Fabrizio Schifano, Francesco Botrè and Matteo Marti
    • 12 May 2021
  • Fibrinolysis in platelet thrombi. (2021) Rahim Kanji, Ying X. Gue, Vassilios Memtsas and Diana Gorog
    • 19 March 2021
  • Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery. (2021) Noelia Perez Diaz, Lisa Lione, Victoria Hutter and Louise Susan Mackenzie
    • 2 February 2021
  • Role, laboratory assessment and clinical relevance of fibrin, factor XIII and endogenous fibrinolysis in arterial and venous thrombosis. (2021) Vassilios Memtsas, Deepa RJ Arachchillage and Diana Gorog
    • 30 November 2020
  • Synthesis and in silico modelling of the potential dual mechanistic activity of small cationic peptides potentiating the antibiotic novobiocin against susceptible and multi-drug resistant Escherichia coli. (2020) Ilaria Passarini, Pedro Ernesto de Resende, Sarah Soares, Tadeh Tahmasi, Paul Stapleton, John Malkinson, Mire Zloh and Sharon Rossiter
    • 22 February 2020
  • Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines. (2020) Pinar Uysal-Onganer, Amy MacLatchy, Rayan Mahmoud, Igor Kraev, Paul R Thompson, Jameel Inal and Sigrun Lange
    • 28 December 2018
  • Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme. (2018) Uchini S Kosgodage, Pinar Uysal-Onganer, Amy MacLatchy, Igor Kraev, Nicholas Chatterton, Anthony P. Nicholas, Jameel Inal and Sigrun Lange
    • 1 September 2017
  • Importance of endogenous fibrinolysis in platelet thrombus formation. (2017) Ying X. Gue and Diana A. Gorog
    • 5 June 2017
  • Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? (2017) Sigrun Lange, Mark Gallagher, Sharad Kholia, Uchini S Kosgodage, Mariya Hristova, John Hardy and Jameel M Inal
    • 9 May 2017
  • Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy. (2017) Uchini S Kosgodage, Rita P Trindade, Paul R Thompson, Jameel M Inal and Sigrun Lange
    • 1 June 2016
  • Identification of excipient-protein interaction hotspots using computational approaches. (2016) Teresa S Barata, Cheng Zhang, Paul A. Darby, Steve Brocchini and Mire Zloh
    • 1 February 2004
  • Molecular similarity of MDR inhibitors. (2004) Mire Zloh and S. Gibbons